{"id":"https://openalex.org/W4386048064","doi":"https://doi.org/10.1097/01.hs9.0000970684.64255.5a","title":"P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY","display_name":"P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY","publication_year":2023,"publication_date":"2023-08-01","ids":{"openalex":"https://openalex.org/W4386048064","doi":"https://doi.org/10.1097/01.hs9.0000970684.64255.5a"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000970684.64255.5a","doi":"https://doi.org/10.1097/01.hs9.0000970684.64255.5a","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1097/01.hs9.0000970684.64255.5a","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1097/01.hs9.0000970684.64255.5a","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072918409","display_name":"Karthik Ramasamy","orcid":"https://orcid.org/0000-0003-3385-3707","observed_orcids":["https://orcid.org/0000-0003-3385-3707"]},"institutions":[{"id":"https://openalex.org/I4210147381","display_name":"Oxford University Hospitals NHS Trust","ror":"https://ror.org/03h2bh287","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210147381"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Karthik Ramasamy","raw_affiliation_strings":["Department of Haematology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom","institution_ids":["https://openalex.org/I4210147381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055916434","display_name":"Hartmut Goldschmidt","orcid":"https://orcid.org/0000-0003-0961-0035","observed_orcids":["https://orcid.org/0000-0003-0961-0035"]},"institutions":[{"id":"https://openalex.org/I4210111460","display_name":"National Center for Tumor Diseases","ror":"https://ror.org/01txwsw02","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529","https://openalex.org/I223822909","https://openalex.org/I2802164966","https://openalex.org/I4210111460"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hartmut Goldschmidt","raw_affiliation_strings":["Sektion Multiples Myelom der Medizinischen Klinik V und des Nationalen Centrums f\u00fcr Tumorerkrankungen (NCT), Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sektion Multiples Myelom der Medizinischen Klinik V und des Nationalen Centrums f\u00fcr Tumorerkrankungen (NCT), Heidelberg, Germany","institution_ids":["https://openalex.org/I4210111460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103143602","display_name":"Philippe Moreau","orcid":"https://orcid.org/0000-0003-1780-8746","observed_orcids":["https://orcid.org/0000-0003-1780-8746"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philippe Moreau","raw_affiliation_strings":["Hematology Department University Hospital H\u00f4tel-Dieu, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department University Hospital H\u00f4tel-Dieu, Nantes, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045814742","display_name":"Maria Teresa Petrucci","orcid":"https://orcid.org/0000-0003-0688-4882","observed_orcids":["https://orcid.org/0000-0003-0688-4882"]},"institutions":[{"id":"https://openalex.org/I2800330116","display_name":"Policlinico Umberto I","ror":"https://ror.org/011cabk38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I2800330116"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria-Teresa Petrucci","raw_affiliation_strings":["OU Policlinico Umberto I, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OU Policlinico Umberto I, Rome, Italy","institution_ids":["https://openalex.org/I2800330116"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027588079","display_name":"David J. Kuter","orcid":"https://orcid.org/0000-0003-2084-8810","observed_orcids":["https://orcid.org/0000-0003-2084-8810","https://orcid.org/0000-0002-7855-2409"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Kuter","raw_affiliation_strings":["Center for Hematology, Massachusetts General Hospital Cancer Center, Boston, MA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Hematology, Massachusetts General Hospital Cancer Center, Boston, MA, United States","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026109406","display_name":"Brian G.M. Durie","orcid":"https://orcid.org/0000-0002-9883-3769","observed_orcids":["https://orcid.org/0000-0002-9883-3769"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Durie","raw_affiliation_strings":["Department of Hematology/Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology/Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, United States","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039180386","display_name":"David F Cella","orcid":"https://orcid.org/0000-0002-9881-4541","observed_orcids":["https://orcid.org/0000-0002-9881-4541"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Cella","raw_affiliation_strings":["Northwestern University Feinberg School of Medicine, Chicago, IL, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University Feinberg School of Medicine, Chicago, IL, United States","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102856622","display_name":"Devender S. Dhanda","orcid":"https://orcid.org/0000-0003-3618-6962","observed_orcids":["https://orcid.org/0000-0003-3618-6962"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Devender Dhanda","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012871103","display_name":"Jin Gu","orcid":"https://orcid.org/0000-0003-3968-8036","observed_orcids":["https://orcid.org/0000-0003-3968-8036","https://orcid.org/0009-0000-6353-0429","https://orcid.org/0000-0002-9650-1963"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jin Gu","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072341536","display_name":"Suvina Amin","orcid":"https://orcid.org/0000-0002-8124-2735","observed_orcids":["https://orcid.org/0000-0002-8124-2735"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suvina Amin","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090920619","display_name":"Thomas Marshall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Marshall","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037561630","display_name":"Pallavi Patwardhan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pallavi Patwardhan","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013008251","display_name":"Susan Meredith Fish","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Fish","raw_affiliation_strings":["Bristol Myers Squibb, Princeton, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, Princeton, NJ, United States","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026151069","display_name":"Ravi Vij","orcid":"https://orcid.org/0000-0001-8795-3610","observed_orcids":["https://orcid.org/0000-0001-8795-3610","https://orcid.org/0000-0001-6358-2392"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ravi Vij","raw_affiliation_strings":["Washington University School of Medicine, Division of Oncology, St. Louis, MO, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine, Division of Oncology, St. Louis, MO, United States","institution_ids":["https://openalex.org/I204465549"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":null,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"S3","first_page":"e642555a","last_page":"e642555a"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.9649999737739563},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.9639999866485596},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":1.0},{"id":"https://openalex.org/keywords/anti-cd38-monoclonal-antibody","display_name":"anti-CD38 monoclonal antibody","score":0.9760000109672546},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.8429999947547913},{"id":"https://openalex.org/keywords/real-world-clinical-outcomes","display_name":"real-world clinical outcomes","score":0.7739999890327454},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9150000214576721},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9959999918937683},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.8849999904632568},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.7239999771118164},{"id":"https://openalex.org/keywords/unmet-medical-needs","display_name":"unmet medical needs","score":0.5659999847412109}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8608688116073608},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5824926495552063},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5667504668235779},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5412229299545288},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4638270139694214},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35007673501968384},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.07510784268379211}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1097/01.hs9.0000970684.64255.5a","doi":"https://doi.org/10.1097/01.hs9.0000970684.64255.5a","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1097/01.hs9.0000970684.64255.5a","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10431287","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10431287","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10431287/pdf/hs9-7-e642555a.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hemasphere","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:bd1aed4ca82c4d4e9db49a604712627f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/bd1aed4ca82c4d4e9db49a604712627f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 7, p e642555a (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000970684.64255.5a","doi":"https://doi.org/10.1097/01.hs9.0000970684.64255.5a","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1097/01.hs9.0000970684.64255.5a","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4386048064.pdf","grobid_xml":"https://content.openalex.org/works/W4386048064.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389247258","https://openalex.org/W4226329036","https://openalex.org/W4417022414","https://openalex.org/W3031241475","https://openalex.org/W4405053172","https://openalex.org/W4389234849","https://openalex.org/W3210680871","https://openalex.org/W4389248212","https://openalex.org/W4308319511","https://openalex.org/W4286298707"],"abstract_inverted_index":{"Topic:":[0],"14.":[1],"Myeloma":[2],"and":[3,23,46,60,84,150,154,246,285,289,296,305,313,316,322,343,376,407,446],"other":[4],"monoclonal":[5],"gammopathies":[6],"-":[7],"Clinical":[8,482],"Background:":[9],"Despite":[10,432],"recent":[11],"treatment":[12,44,82,182,434],"advances":[13],"in":[14,49,112,117,133,152,164,170,265,293,339,348,471],"multiple":[15],"myeloma":[16,485],"(MM),":[17],"it":[18],"remains":[19],"an":[20],"incurable":[21],"disease,":[22],"a":[24,67,194,300,423,428],"significant":[25],"proportion":[26],"of":[27,76,167,180,197,303,327,354],"patients":[28,113,145,168,188,192,240,250,263,318,437,472],"eventually":[29],"relapse":[30],"or":[31,105,242],"become":[32],"refractory":[33],"to":[34,55,80,94,228],"their":[35],"latest":[36],"treatment.":[37],"Limited":[38],"information":[39],"is":[40,420],"available":[41,177],"on":[42,422],"real-world":[43,118,418,452],"patterns":[45,83,445],"clinical":[47,85,119,442,447],"outcomes":[48,86,448],"triple-class":[50],"exposed":[51,54],"(TCE;":[52],"i.e.":[53],"immunomodulatory":[56],"drugs,":[57],"proteasome":[58],"inhibitors,":[59],"anti-CD38":[61],"antibodies)":[62],"relapsed/refractory":[63],"MM":[64,149],"(RRMM)":[65],"patients,":[66],"population":[68,166,426],"with":[69,114,146,241,427],"high":[70,429],"unmet":[71,430],"need.":[72,431],"Aims:":[73],"The":[74,159,175,220,308],"objective":[75],"this":[77,451],"analysis":[78,161,273],"was":[79,162,184,208,226,280,332,359,365,392,400,409],"describe":[81],"(overall":[87],"survival":[88,91,98],"[OS];":[89],"progression-free":[90],"[PFS];":[92],"time":[93],"progression":[95],"[TTP];":[96],"event-free":[97],"[EFS]),":[99],"which":[100,213],"included":[101],"progression,":[102],"subsequent":[103,195,206,474],"treatment,":[104,212],"death":[106],"from":[107,127,329,356,450],"any":[108],"cause":[109],"as":[110,210],"events)":[111],"TCE":[115,202,221,236,239,271,295,330,341,374,424,439,463],"RRMM":[116,151,222,272,425,436,464],"practice.":[120],"Methods:":[121],"We":[122],"analyzed":[123,232],"prospectively":[124],"collected":[125],"data":[126,449],"the":[128,155,165,186,201,204,217,261,286,294,340,349,373,384,388,455],"multicenter":[129],"Prospective":[130],"REsearch":[131],"Assessment":[132],"Multiple":[134,484],"Myeloma:":[135],"An":[136],"oBservationaL":[137],"Evaluation":[138],"(PREAMBLE)":[139],"registry":[140,143],"[NCT01838512].":[141],"PREAMBLE":[142,171],"includes":[144],"newly":[147],"diagnosed":[148],"Europe":[153,284],"United":[156],"States":[157],"(US).":[158],"current":[160],"conducted":[163],"enrolled":[169,264],"who":[172,251],"were":[173,231,268,310,319],"TCE.":[174,190],"earliest":[176],"end":[178],"date":[179,187,215,331,358],"third":[181],"class":[183],"considered":[185],"became":[189],"If":[191],"received":[193,252],"line":[196],"therapy":[198],"(LOT)":[199],"after":[200,256],"date,":[203],"first":[205],"LOT":[207,255,475],"defined":[209,216],"index":[211,218,244,357],"start":[214],"date.":[219],"study":[223,419,453],"identification":[224],"period":[225],"16-Nov-2015":[227],"31-Dec-2020.":[229],"Patients":[230,292],"across":[233],"two":[234],"cohorts:":[235],"cohort":[237,248,298,342],"(all":[238],"without":[243],"treatment)":[245],"post-TCE":[247,276,297,350,385,389],"(those":[249],"\u22651":[253],"additional":[254],"becoming":[257],"TCE).":[258],"Results:":[259],"Of":[260],"2,206":[262],"PREAMBLE,":[266],"377":[267],"eligible":[269],"for":[270,372,383,457,462],"(including":[274],"194":[275],"patients).":[277],"Patients\u2019":[278],"location":[279],"evenly":[281],"split":[282],"between":[283],"US":[287],"(51.5%":[288],"48.5%,":[290],"respectively).":[291,324],"had":[299,440],"median":[301],"age":[302],"70.0":[304],"69.0":[306],"years.":[307],"majority":[309],"male":[311],"(56.5%":[312],"53.6%,":[314],"respectively),":[315],"most":[317],"white":[320],"(79.3%":[321],"78.4%,":[323],"Median":[325,352],"length":[326,353],"follow-up":[328,355],"7.0":[333],"months":[334,345,361,367,378,394,402,411],"(standard":[335],"deviation":[336],"[SD],":[337],"10.7)":[338],"11.1":[344],"(SD,":[346,362],"10.9)":[347],"cohort.":[351,386],"10.0":[360],"10.6).":[363],"OS":[364],"16.2":[366],"(95%":[368,379,395,403,412],"CI":[369,380,396,404,413],"13.5,":[370],"23.5)":[371],"cohort,":[375,390],"18.3":[377],"14.0,":[381],"25.9)":[382],"For":[387],"PFS":[391],"4.9":[393,410],"3.5,":[397],"5.8),":[398],"TTP":[399],"6.0":[401],"4.9,":[405],"7.4)":[406],"EFS":[408],"3.6,":[414],"5.9).":[415],"Summary/Conclusion:":[416],"This":[417],"focused":[421],"new":[433],"advances,":[435],"following":[438],"poor":[441],"outcomes.":[443],"Treatment":[444],"highlight":[454],"need":[456],"novel":[458],"more":[459],"efficacious":[460],"treatments":[461],"patients.":[465],"Figure:":[466],"Progression":[467],"Free":[468],"Survival":[469],"(PFS)":[470],"receiving":[473],"post-triple-class":[476],"exposureKeywords:":[477],"Survival,":[478],"Real":[479],"world":[480],"data,":[481],"outcome,":[483]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2023-08-23T00:00:00"}